|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
There had been evidence that low-dose local IFN could be beneficial in the management of recurrent oral ulcers (OUs). We investigated the efficacy and collected initial data on the safety of low-dose natural human IFN-alpha administered by the oral mucosal route in Behçet's syndrome (BS) in a placebo controlled, double blind study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1462-0332
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1388-91
|
|
pubmed:meshHeading |
pubmed-meshheading:19717547-Administration, Oral,
pubmed-meshheading:19717547-Adolescent,
pubmed-meshheading:19717547-Adult,
pubmed-meshheading:19717547-Aged,
pubmed-meshheading:19717547-Behcet Syndrome,
pubmed-meshheading:19717547-Double-Blind Method,
pubmed-meshheading:19717547-Drug Administration Schedule,
pubmed-meshheading:19717547-Female,
pubmed-meshheading:19717547-Humans,
pubmed-meshheading:19717547-Interferon-alpha,
pubmed-meshheading:19717547-Male,
pubmed-meshheading:19717547-Middle Aged,
pubmed-meshheading:19717547-Oral Ulcer,
pubmed-meshheading:19717547-Tablets,
pubmed-meshheading:19717547-Treatment Outcome,
pubmed-meshheading:19717547-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.
|
|
pubmed:affiliation |
Division of Rheumatology, Cerrahpa?a Medical Faculty, University of Istanbul, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
